New Magenta Catalyst MGTA-145 After Company Drops MGTA-456 Phase II Trial

By |2020-06-27T15:59:19-04:00June 26th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment, SanaCurrents Updates|Tags: |

Shares of Magenta Therapeutics (NASDAQ: MGTA) declined 22% on June [...]